The Utilization of Stem Cells for Renewal of the Central Nervous System
ABSTRACT-Literature Review
Amyotrophic lateral sclerosis (ALS) and Spinal Cord Injury
(SCI) are aggravating neurological circumstances that affect people all over
the globe, considerably decreasing the value of existence, both for the sick
persons and their families.
Aim
The current Assessment endeavors to sum up the numerous recuperative
strategies being established for the restoration of the spinal twine, the
application of diverse stem cell kinds, and the contemporary familiarity
concerning stem cell remedy.
Technique
Appraisal of the writings from the last ten years of human
research utilizing stem cell translocation as the key remedy, in the company of
adjuvant remedies or not.
Summary
The present analysis provides a synopsis of the situation of
the art concerning the restitution of the spinal cord and acts as a beginning position
for upcoming research.
The Utilization of
Stem Cells for Renewal of the Central Nervous System
Introduction
For many years, the spinal cord was viewed as a hose that simply
linked the mind to the diverse human body structures and organs. This basic outlook altered courtesy of the
dazzling input of Sir Charles S. Sherrington, whose renowned monograph The Integrative Action of the Nervous System,
explicated how the Central Nervous System is systematized. Through the
monograph, Sherrington resolved the venerable argument between the Neuron Doctrine that proposed that
neurons communicate with another through synapses and the Reticular Theory that suggested that neurons are contiguous
physically (Burke, 2006). The other strong conviction at the period was that
the Central Nervous System was not capable of redeveloping. This observation
was disputed when Santiago Ramon Y Cajal demonstrated that the transected
animal spinal cords were, in fact, capable of redeveloping; Nevertheless, this impulsive
reproduction lasted for merely around ten to fourteen days (Ridler, 2017). This
literature reviews the methods through which stalk unit remedy can advance
spinal cord reproduction in human beings. The study focuses on two dissimilar
pathologies: Amyotrophic Lateral Sclerosis (ALS) and Spinal Cord Injury (SCI).
Spinal Cord Injury (SCI) is a disturbing ailment with a prevalence
of twelve thousand new occurrences every year in the U S single-handedly. As
per the National Spinal Cord Injury Statistical Center, the main roots of
Spinal Cord Injury (SCI) are sports (7.8 percent), violence (15 percent), falls
(27.3 percent), and automobile accidents (41.7 percent) (NSCISC, 2010).
A Spinal Cord Injury laceration is fundamentally severe
ischemia that creates damage to vertebral ligaments, discs, and bones (Leal-Filho,
2011). Typically, it is caused by a compression or a contusion. The attentiveness
of lethal changeable and the ischemia itself add to the demise of cells and
necrosis that may create resulting lacerations that take place at the cellular point
and are mostly more complicated. By jamming action perspective, deregulating
the balance of ion, creating glutamatergic excitotoxicity and lipid
peroxidation, the resulting abrasions can create operational disturbances like
swelling, axonal damage, necrosis, and the death of cells. These occurrences that
are noxious may consequently result to other pathologies like persistent
neuropathic ache (Leal-Filho, 2011).
Instantaneously after harm, astrocytes play a serious
role in the formation of glial scratches. Glial blemishing fuels axonal
reproduction; after CNS damage, it separates the tissue of the nerve from provocative
cells, consequently sustaining chemical and physical uprightness (Afshari,
Kwok, White, & Fawcett, 2010). Conversely, glial scarring is also in charge
of averting axonal invasion, consequently preventing neuroreproduction. Even if
glial scarring is a crucial contributor to reproduction, only some axons can traverse
the glial scratch as prematurely as twenty-eight days following a SCI (Leal-Filho,
2011).
Amyotrophic lateral sclerosis (ALS); (in addition identified
as Lou Gherig’s illness, motor neuron ailment, or Charcot sickness) is a
neurodegenerative ailment in which a growing paralysis results to demise, often
through respiratory breakdown, in thirty-six to sixty months of the initial
warning signs (Al-Chalabi et al., 2012). Only five percent of sick persons with ALS
have a kin history. However, a widespread kin history typically enhances the
likelihood of developing ALS. ALS starts focally and extends closely. It may
initially come out as paralysis in a single leg or hand, or as dyspnea or
dysarthria, and then advances increasingly to other parts of the body, creating
characteristic lower movement neuron warning signs. As neurons of the frontal
horn pass away, movement axons vanish, resulting in a decline in the amplitude
of strength accomplishment prospective. Therefore, according to Al-Chalabi et
al., electromyography (EMG) is a valuable apparatus to detect ALS and rule out
other pathologies like other mobility neuron ailments, neuromuscular disorders,
and peripheral neuropathies.
ALS takes place in around two out of each one hundred
thousand persons every year. As pinpointed by Al-Chalabi et al. (2012), the
most distressing element of this medical situation is that when the initial
warning signs pop out, the pathology is by now well in progress. It is hard to establish
the factors that add to deterioration and the ones that are merely costs of the
cellular adjustment brought about by the circumstance itself. Nevertheless, it
is well-known that extreme glutamate, a bother in protein dilapidation, and
mitochondrial deficits, are some major attributes of this health condition.
It is rational to presume that any damage to the spinal twine
will lead to grave outcomes, whether it is caused by genetic predisposition or
trauma. According to Al-Chalabi et al. (2012), these consequences depend on the
level and type of damage. Damages to the spinal cord can be divided into two
categories: incomplete and complete. A total damage insinuates that there is no
function below the level of the damage; no voluntary movement and no sensation.
Both sides of the body are affected equally.
An
incomplete damage insinuates that there is some function below the key level of
damage. An individual with an incomplete damage may have the ability to move
one limb more than the other, may have the ability to feel fractions of the
body that are immobile, or may experience more functioning one half of the body
than the other. With advancements in
acute management of central nervous system damages, incomplete damages are
getting more common (Al-Chalabi et al., 2012).
The stage of damage is very useful in predicting what areas
of the body might be impacted by loss of function and paralysis. It should be
noted that in incomplete damages, there will be some disparity in these
prognoses.
Neck (cervical) damages normally lead to quadriplegia.
Damages above the C-4 stage may need a ventilator for the victim to breathe.
C-5 damages mostly lead to biceps and shoulder control, but no control at the
hand or wrist. C-6 damages normally result in wrist control, but no functioning
of the hand (Al-Chalabi et al., 2012).
Persons with T-1 and C-7 damages can stretch their arms.
However, they may still have dexterity issues with the fingers and hands.
Damages at the thoracic area and below lead to paraplegia, but the hands are
not impacted. At T-1 to T-8, most often the control of the hands is present,
but the control of the trunk is poor as a result of the lack of control of the
abdominal muscle. However, sitting balance is quite excellent. Sacral and Lumbar spinal cord dames result in
reduced control of the legs and hip flexors (Al-Chalabi et al., 2012).
Apart from a loss of motor function or sensation, persons
with spinal cord damage also experience other alterations. For instance, they
may experience bladder and bowel dysfunction. Very high dames (C-1, C-2) can
lead to a loss of several involuntary functions such as the capability to
breathe, leading to the requirement of breathing aids like diaphragmatic pacemakers
or mechanical ventilators (Al-Chalabi et al., 2012).
There are also other impacts of spinal cord damage such as
chronic pain, the lack of ability to sweat below the area of damage, decreased control
of body temperature, the lack of ability to regulate blood pressure
effectively, and low blood pressure (Al-Chalabi et al., 2012).
One potential way of reproducing the CNS is stalk unit
translocation. Most of the contemporary study in this sector of research is devoted
to recognizing the kind of cell that can advance reproduction in the greatest
harmless and efficient method (Al-Chalabi et al., 2012). Apart from the type of
cell, other aspects that are critical to the structural and functional restoration
of damaged neurons include; relations with the host tissue, synaptogenesis, and
electrophysiological properties (Mackay-Sim & St John, 2011).
The aim of cell translocation is to advance neural
reproduction and useful neural revival by improving the host reproductive
capability with neurotrophic dynamics.
This advances axonal reproduction and restores lost neurons (Al-Chalabi
et al., 2012).
Schwann
Cells (SCs)
Cells referred to as Schwann (SCs) are in charge of
generating the myelin covering and control bands utilized in axonal and remyelination
reproduction after damage. When
resettled, Schwann cells (SCs) make numerous neurotrophic factors like CNTF,
BDNF, and NGF that add to neuronal endurance and to the production of
extracellular matrix proteins and cell bond molecules that prop axonal
development. Glial wounds, a powerful natural obstruction, embody an impediment
for SC relocation, as do chondroitin sulfate proteoglycan (CSPG) ephrins, and
aggrecan (Li & Lepski, 2013).
In a proportional research with olfactory ensheathing cells
(OECs), it was found that SCs associated with astrocytes, making them reproduce
and develop. Additionally, the myelinated axons were separated into categories (Zhou
et al., 2012). There was a considerably improved appearance of glial fibrillary
acid protein (GFAP); around 5.95 percent more than was observed for OECs twenty
one days post inoculation and around 3.71 percent more than was observed for
OECs forty two days after the inoculation. According to Zhou et al., SC relocation
was extra concerted at the place of damage, however, the OECs a larger detachment,
and even infiltrated the ordinary tissue. Even if both cell forms were proficient
to impact useful recuperation, OECs were extra triumphant at it.
In a research that was longitudinal and undertaken with
human partakers in China, researchers investigated the translocation of SCs in
six sick persons and monitored the findings for more than sixty months. At the
conclusion of the investigation, they detailed autonomic, motor and sensory
enhancements in all the sick persons (Zhou et al., 2012). MRI scans indicated
that the cystic and myelomalacia deterioration had also been decreased. Even if the results of the study showed
potential, it contained some drawback: sick persons were not harmonized for
variables like ASIA scale, period since SCI, and age.
In another research
that followed a longitudinal research approach, Saberi et al. (2011) endeavored
to assess the feasibility and safety of SC translocation. In the two pieces of
research, no important transformations in sick persons’ MRI examinations were
documented, and they documented neither neurological enhancement nor worsening.
They just documented useful autonomic revival and enhanced excellence of life.
Neural
Shoot Cells
Initially illustrated by Altman in the 1960s, these
multi-potent cells possess the prospect of getting into any type of cell in the
CNS. These stanch cells are leftovers from the neuroectoderm of early on
embryos and are there in adult, fetal, and embryonic nervous system (Liebau,
Vaida, Storch & Boeckers, 2007). During growth, these cells split and separate
to make up the key elements of the CNS, i.e., the spinal cord and the brain. In
maturity, stem cells reduce in quantity and get restricted to particular areas
like the spinal cord, and to a huger degree, subgranular region of the
hippocampal dentate gyrus (SGZ) and the subventricular region (SVZ).
From 2010 to 2011, Glass et al. (2012) enlisted twelve sick
persons to assess the wellbeing of NSC translocation. They split sick persons
into four categories: B and C (ambulatory sick persons) and A1 and A2
(non-ambulatory patients). Categories C and A2 got five bilateral injections
NSCs (ten injections in total) while categories B and A1 got five unilateral
injections. The researchers undertook a laminectomy at T11-T12 and infused the
cells. Merely undesirable effects associated directly with the inoculation process
were documented. No negative or positive outcomes were achieved. However, the
researchers considered the trial triumphant since it revealed the wellbeing of
the procedure.
Moviglia et al. (2013) expressed a dissimilar approach in
which they utilized a T-cell vaccine with a method conveyed as BEN (Bone marrow
mesenchymal stroma cells, Effector T cells, and Neuroblasts). The collective
remedy aimed to recreate the immunological circumstances that were at hand
before the restoration (i.e., during the severe stage), to make sure the
appropriate budding of neuroblasts. No one of the seven sick persons handled
reported side effects, and one sick person indicated some enhancement in
critical functions. No considerable signs of motor recuperation were recorded. The
researchers concluded that the technique is safe and feasible.
Olfactory
Encasing Cells
Neurodevelopment in the olfactory structure keeps on
occurring all through an individual’s existence (Mackay-Sim & St John,
2011). Stem cells multiply to produce
fresh sensory neurons in the basal cover of the olfactory epithelium. In the vital
nervous structure, stem cells multiply in the subventricular region of the frontal
brain, producing neural progenitors that move to the olfactory corm to generate
fresh interneurons. If damage occurs, the neurons are instantaneously restored
via a rush in neuroproduction. Their
axons develop out via the basal covering of the epithelium, enter the
subterranean casing and penetrate the laminae propia, creating axon bunches
that are enclosed by OECs. The bunches enter the cranium and get to the
olfactory corm, where they create synapses with interneurons and mitral cells.
OECs encircle the axons of the sensory neurons in the olfactory epithelium and
establish synapses in the dedicated glomeruli of the olfactory corm in the mind.
As a result of their capability to steer the links between the Central Nervous
System (CNS) and Peripheral Nervous System (PNS), and their capability set
apart into non-olfactory cell forms, these multi-effective cells are
outstanding runners for translocation of cells.
Huang et al. (2008) picked thirty-five sick persons and
split them into two categories: an investigational category (n=15) that got
OECs obtained from fetal olfactory corm and a control category (n=20). The
investigational category did not describe any undesirable outcomes, insinuating
that OEC translocation may slug the progression of malady.
In another research
with forty-two sick persons, thirty-five got OEC translocations two times, five
got translocations three times, one got translocations four times, and another
got them five times (Chen et al., 2012). The researchers documented that all
the sick persons recuperated neurological function, and none encountered side
effects like disruption of neural systems, infections, cyst formations, edema,
hemorrhages, or tumors. In addition, thirty-five sick persons demonstrated
enhancements in EMG, and one sick person demonstrated pulmonary function
enhancement; however, just subsequent to the fourth translocation, and staying steady
even following the fifth translocation.
Embryonic
Shoot Units
Nascent Shoot Cells (ESCs) are a kind of pluripotent cell
gotten in the blastocyst that has the capability to differentiate into the
three basic gem layers and produce all types of cells. This capability makes
these cells the ideal nominees for cell remedy (Li & Lepski, 2013). Neural distinguished
ESCs may grow into neurons, astrocytes or oligodendrocytes. Numerous moral
issues surround the utilization of human being ESCs because acquiring them
needs the annihilation of numerous fertilized ocytes or human embryos.
A key concern regarding the application of ESCs is the
development of growths like teratomas. In a research, Matsuda et al. (2008)
documented the development of tumors three weeks after translocation when each
and every behavioral enhancement had ended. They then got the capability to
repress tumorigenesis in a coculture with Bone Marrow Stromal Cells (BMSC).
In spite of the apprehension of growth development,
researchers at the Geron Corporation started medical tests utilizing ESC-gotten
OPCs (GRNOPC1) given in five days of harm (Matsuda et al., 2009). No
undesirable occurrences were documented during the long-standing report on.
Induced
Pluripotent Stem Cells (iPSCs)
Takalashi and Yamanaka (2006) applied four transcription
dynamics, that is, Klf4, c-Myc, Sox2, and Oct3/4, to produce pluripotent cells,
consequently known as iPSCs straightforwardly from adult fibroblast or mouse
embryonic cultures. Considerations like supplementation, culture medium, and dynamic
stoichiometry have been illustrated to impact the quality of the iPSCs
generated (Bhangra et al., 2016).
Wang et al. (2011) obtained neural crest stanch units from iPCs
of humans and embryonic shoot units. The neural crest stalk units were planted
into nonofibrous tubular scaffolds (electro-spun poly)
(l-lactide-co-caprolactone) and utilized as a conduit for transected sciatic nerves
in a mice mock-up. Electrophysiological study indicated that neural crest shoot
unit-enembeded nerve bridges led to a hastened reproduction of sciatic nerves
at thirty days when contrasted with restrictions. Histological investigations
illustrated that neural crest shoot unit translocation led to separation into
Schwann units that were capable to myelinate the host axons. No development of
teratoma was witnessed for up to twelve months after the neural crest shoot
unit translocation in vivo. Related
outcomes were derived by Uemura et al. (2014) who investigated the lengthy run
result of translocating iPSC-obtained neurospheres in nerve channels for
marginal nerve restoration in rats (Bhangra et
al., 2016). They validated that no formation of teratoma was witnessed
up to forty-eight weeks following translocation, and axonal reproduction and
myelination were improved.
Ikeda et al. (2014) tried to restore sciatic nerve damage in
a rat mock-up by applying a bioabsorbable nerve channel that had both
iPSC-obtained neurospheres and a fundamental fibroblast development dynamic
system of delivery. The iPSCs were cultured and separated into basic
neurospheres that had neural shoot units then secondary neurospheres that as
per Nori et al. (2011) distinguished largely into glial lineage units. Axon
reproduction and practical revival in the rats were documented to be enhanced
three months after recreation when this amalgamation strategy was applied (Bhangra et al., 2016).
The acquirement of iPSCs from somatic units offers much prospective
for sick person-particular cell remedy that bypasses immune negative response concerns
and moral issues related with utilizing embryonic shoot units as a source of
cell. Nevertheless, numerous critical concerns have to be tackled so as to
utilize iPSCs in neural tissue reproduction, like dissimilarities in iPSC
populations in separation and development and the suitable differentiation
level of the units for particular tissue reproduction utilizations (Bhangra et al., 2016).
Mesenchymal Stem Cells as Practical Sources of Stem Cells for Central
Nervous System Utilizations in Multiple Sclerosis
Multiple sclerosis (MS) is a resistance-mediated demyelinating
sickness of the essential nervous structure related to a progressive clinical
course and significant cognitive or physical cognitive or physical disability. Provided
the aberrant resistance reaction underlying MS pathogenesis, contemporary
sickness-modifying therapies for MS comprise of immunomodulatory remedies.
Nonetheless, the therapies are merely partially effectual in slowing down the
progressive stage of MS that maybe hugely neurodeproductive or/and may engross
independent abnormalities in resistant function that are not as acquiescent to
this kind of remedy. Therefore, an imperative necessity for remedies that can
halt or turn around the development of MS via approaches that aim deproductive
illness processes in the CNS. Precisely, the reproductive prospective of
cell-founded biological remedies is a dynamic region of examination for the management
of MS (Matsuda et al., 2009).
The advancement of cell-founded repair approaches for MS counters
the challenge of delivery to multifocal injuries all over the spinal cord and
the brain. Provided this pathology, a practical approach for CNS distribution
of therapeutic trunk units is to deliver them into the cerebrospinal liquid. Additional
challenges comprise compatibility with the CNS surroundings so as to evade immune
activation or ectopic tissue formation that might aggravate the already inflammatory
circumstance in MS. Consequently, a foremost approach is to exploit the CNS reproductive
prospective of an autologous supply of units by intrathecal delivery (Matsuda
et al., 2009).
Bone marrow mesenchymal trunk unit-obtained neural
progenitors (MSC-NPs) are a prospective restorative supply of units that have
been indicated to be effective in a preclinical model of multiple sclerosis
(MS). To investigate the viability of applying MSC-NPs as an autologous supply
of units to advance central nervous system (CNS) restoration, a research typified
MSC-NPs from a team of both non-MS and MS donors. Broadened MSCs indicated
similar attributes concerning cell surface phenotype and growth, in spite of
the disease status of the donor. MSC-NPs obtained from all MSCs indicated a reliable
pattern of gene appearance transformations that correlated with enhanced
homogeneity and neural commitment. Moreover, the decreased appearance
alterations of mesodermal markers decreased aptitude for adipogenic or
osteogenic delineation in MSC-NPs compared with MSCs implied that MSC-NPs have
decreased prospective of unneeded mesodermal separation upon CNS translocation.
The immunoregulatory utility of MSC-NPs was the same as that of MSCs in their
capability to repress T-cell propagation and to advance growth of
FoxP3-positive T regulatory units in vitro. Additionally, MSC-NPs advanced
oligodendroglial separation from brain-obtained neural trunk units that
correlated with the discharge of bioactive dynamics. These findings offer a set
of uniqueness attributes for autologous MSC-NPs and imply that the in vitriol
immunoregulatory and trophic aspects of these units may possess restorative worth
in the management of MS (Matsuda et al., 2009).
Use of Fetal Tissue Translocations to Treat
Parkinson’s Sickness
Parkinson’s sickness is a progressive disorder of motor
control that distresses around two percent of individuals aged sixty five years
and above. Activated by the demise of neurons in an area of the brain known as
the substantia nigra, this sickness starts with trivial tremors that advance to
bodily and limb stiffness and intricacy commencing movement (Matsuda et al.,
2009).
The rigorous studies endeavoring to cure Parkinson’s illness
with trunk units is an excellent case for the numerous approaches, triumphant
outcomes, and outstanding challenges of trunk unit-founded brain restoration (Matsuda
et al., 2009).
Scientists transplanted basic life units obtained from fetal
tissue from the substantia nigra of mouse into the eye of a mature rat and
found that it developed into mature dopamine neurons. Later, several studies
indicated that translocation of this kind of tissue could turn around
Parkinson’s-like indicators in monkeys and mice when put in the injured
regions. In human trials, some sick persons indicated a dwindling of their
warning signs. Additionally, scientists could evaluate an enhancement in
dopamine neuron utility in the striatum of these sick persons by utilizing a technique
of brain-imaging known as positron emission tomography (PET). The PET scans of these
sick persons indicated that some of the translocated dopamine neurons endured and
grew (Matsuda et al., 2009).
Concluding
Interpretations
The field of neural repair and cell remedy has witnessed
major progress in the last few decades. Plentiful pre-medical data backs the
idea that cell translocation advances restoration in the SCI beast model.
Nevertheless, more studies have to be undertaken to find out: the type of cell
or translocation methods that have the capability to prevail over the hostile
micro-surroundings and facilitate the repair of injured neural tissue, the type
of cell that possesses the greatest neurogenic prospective, and, most
importantly, the kind of cell that is most appropriate for translocation.
Obviously, biological safety has to be ensured prior to the
inclusion of stem cell-founded treatments in the medical armamentarium. For
example, a cell’s tendency to produce tumors has to be considered. Any type of genetic manipulation where cells
are changed into more primitive stages sets off larger proliferation rates and
thus cumbers a larger prospective for malignant cells. Nuclear transfer and
Lentiviral assays undertaken with full-grown somatic units resolve the issue of
stem-cell basis. Nonetheless, they do not resolve the issue of lump
development. Thus, even if promising, these methods are not yet ready for
extensive application.
The other promising strategy that is presently under
creation is the employment of autologous stanch cells that can be motivated to
split into more established neurons to refill injured regions. With this
procedure, the cells possess the comprehension regarding the dynamics and cell
indicating flows that advance neuronal segregation and ultimately,
re-establishment.
As a final point, the restructuring of indigenous neural trails,
assisted by the refilling of the destroyed tissue with freshly produced
neurons, either recruited or implanted indigenously, is critical for
reestablishing neural operation. The means past this procedure, and means to meddle
with it, is hugely not known and need more illumination.
Conceivably, the subsequent stride in this procession of
study has to be to utilize permutations of dissimilar stem cell translocations,
because it has been demonstrated that every cell variety has the ability to
recuperate merely a section of the lost tissue. To put it differently, no
single type of cell can recover a whole area made up of dissimilar cells with
diverse functions alone. Applying an amalgamation of dissimilar cells would let
the personage action of every kind to potentiate the action of the rest of the
cells.
In Summary, the systematic development of the past numerous
years has inputted substantially to the comprehension of neural restoration and
its probable applications. Hopeful results have been witnessed in efforts with
beasts and in preliminary medical tests with human partakers. Nonetheless,
there is still a lot to comprehend concerning stem cell natural science and the
pathophysiology of neurodegenerative ailments.
Light can be seen at the end of the burrow and founded on the speedy
advancement in latest years, and the light is not likely to grow fainter.
<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-3557122163696795"
Contact:
Email address: researchwriters087@gmail.com
References
Afshari, F., Kwok, J., White, L.,
& Fawcett, J. (2010). Schwann cell migration is integrin-dependent and inhibited by
astrocyte-produced aggrecan. Glia, NA-NA. http://dx.doi.org/10.1002/glia.20970
Al-Chalabi, A., Jones, A., Troakes,
C., King, A., Al-Sarraj, S., & van den Berg, L. (2012). The genetics and neuropathology of amyotrophic
lateral sclerosis. Acta Neuropathologica, 124(3),
339-352. http://dx.doi.org/10.1007/s00401-012-1022-4
Burke, R. (2006). Sir Charles
Sherrington's The integrative action of the nervous system: a centenary
appreciation. Brain, 130(4), 887-894. http://dx.doi.org/10.1093/brain/awm022
Bhangra,
K. S., Busuttil, F., Phillips, J. B., & Rahim, A. A. (2016). Using stem
cells to grow artificial tissue for
peripheral nerve repair. Stem Cells International, 2016.
Chen,
L., Chen, D., Xi, H., Wang, Q., Liu, Y., & Zhang, F. et al. (2012).
Olfactory ensheathing cell
neurorestorotherapy for amyotrophic lateral sclerosis patients: Benefits from
multiple transplantations. Cell
Transplantation. http://dx.doi.org/10.3727/096368911x633789
Glass, J., Boulis, N., Johe, K.,
Rutkove, S., Federici, T., & Polak, M. et al. (2012). Lumbar
Intraspinal Injection of Neural Stem Cells in Patients with Amyotrophic Lateral Sclerosis:
Results of a Phase I Trial in 12 Patients. STEM CELLS, 30(6), 1144-1151. http://dx.doi.org/10.1002/stem.1079
Huang,
H., Chen, L., Xi, H., Wang, H., Zhang, J., Zhang, F., & Liu, Y. (2008).
Fetal olfactory ensheathing cells
transplantation in amyotrophic lateral sclerosis patients: a controlled pilot study. Clinical
Transplantation, 22(6), 710-718. http://dx.doi.org/10.1111/j.1399- 0012.2008.00865.x
Leal-Filho, M. (2011). Spinal cord
injury: From inflammation to glial scar. Surgical Neurology International, 2(1),
112. http://dx.doi.org/10.4103/2152-7806.83732
Li, B., Xu, C., Zhang, J., Li, Y.,
& Duan, Z. (2012). Differing Schwann Cells and Olfactory
Ensheathing Cells Behaviors, from Interacting with Astrocyte, Produce Similar
Improvements in Contused Rat Spinal Cord's Motor Function. Journal Of Molecular Neuroscience, 48(1),
35-44. ttp://dx.doi.org/10.1007/s12031-012-9740-6
Li, J., & Lepski, G. (2013).
Cell Transplantation for Spinal Cord Injury: A Systematic Review. Biomed Research International, 2013,
1-32. http://dx.doi.org/10.1155/2013/786475
Liebau, S., Vaida, B., Storch, A.,
& Boeckers, T. (2007). Maturation of Synaptic Contacts
in Differentiating Neural Stem Cells. Stem Cells, 25(7),
1720-1729. http://dx.doi.org/10.1634/stemcells.2006-0823
Mackay-Sim, A., & St John, J.
(2011). Olfactory ensheathing cells from the nose: Clinical application in human spinal cord
injuries. Experimental Neurology, 229(1), 174-180. http://dx.doi.org/10.1016/j.expneurol.2010.08.025
Matsuda, R., Yoshikawa, M., Kimura,
H., Ohji, Y., Nakase, H., Ishizaka, S., & Sakaki, T. (2008).
Co-transplantation of ES cells and bone marrow stromal cells for spinal cord injury
suppresses tumor development. Cell Research, 18,
S137-S137. http://dx.doi.org/10.1038/cr.2008.227
Matsuda, R., Yoshikawa, M., Kimura,
H., Ouji, Y., Nakase, H., & Nishimura, F. et al. (2009). Cotransplantation of
Mouse Embryonic Stem Cells and Bone Marrow Stromal
Cells Following Spinal Cord Injury
Suppresses Tumor Development. Cell
Transplantation, 18(1), 39-54. http://dx.doi.org/10.3727/096368909788237122
Moviglia, G., Moviglia-Brandolino,
M., Varela, G., Blasetti, N., Piccone, S., & Albanese, G. (2013). T cell vaccination
for chronic progressive multiple sclerosis 18 years of
clinical follow-up. Cytotherapy, 15(4), S40. http://dx.doi.org/10.1016/j.jcyt.2013.01.150
NSCISC. (2010). The 2010 Annual
Statistical Report for the Spinal Cord Injury Systems. Birmingham, Alabama.: NSCISC.
Ridler, C. (2017). Spinal cord
injury: Insights into life expectancy after spinal cord injury. Nature Reviews Neurology, 13(5), 258-258. http://dx.doi.org/10.1038/nrneurol.2017.53
Riley, J., Federici, T., Polak, M.,
Kelly, C., Glass, J., & Raore, B. et al. (2012). Intraspinal
Stem Cell Transplantation in Amyotrophic Lateral Sclerosis. Neurosurgery, 71(2),
405-41 http://dx.doi.org/10.1227/neu.0b013e31825ca05f
Saberi, H., Firouzi, M., Habibi, Z.,
Moshayedi, P., Aghayan, H., & Arjmand, B. et al. (2011). Safety of intramedullary
Schwann cell transplantation for postrehabilitation spinal cord injuries: 2-year follow-up of 33 cases. Journal
Of Neurosurgery: Spine, 15(5),
515-525. http://dx.doi.org/10.3171/2011.6.spine10917
Zhou, X., Ning, G., Feng, S., Kong,
X., Chen, J., & Zheng, Y. et al. (2012). Transplantation
of Autologous Activated Schwann Cells in the Treatment of Spinal Cord Injury:
Six Cases, More than Five Years of Follow-up. Cell Transplantation, 21(1_suppl),
39-47. http://dx.doi.org/10.3727/096368912x633752
Comments